ArticlePharmaceutics2021

Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial.

Mustafa Erelel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.